New scan aims to predict cancer treatment success
NCT ID NCT05404048
Summary
This study is testing a new type of PET/CT scan that uses a special tracer to look at a protein called PD-L1 in the body. Researchers want to see if this scan can help predict which patients with large B-cell lymphoma will respond well to CAR-T cell therapy. The study also aims to help doctors tell the difference between active cancer and harmless inflammation after treatment using imaging.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Medical Center Groningen
Groningen, 9713GZ, Netherlands
Conditions
Explore the condition pages connected to this study.